SCHEMBL2530149

SCHEMBL2530149

CC1(C)Cc2c(C(=O)O)ccc(F)c2NC1c1cccc(N2CCOCC2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.43
KMO O15229 1/20 0.42
SETD2 Q9BYW2 1/20 0.40
PRKDC P78527 2/20 0.38
CYP3A4 P08684 2/20 0.37
KIF11 P52732 1/20 0.37
FAAH O00519 1/20 0.36
PIK3CD O00329 1/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CB P42338 1/20 0.36
PIK3CG P48736 1/20 0.36
BRD4 O60885 1/20 0.35
CREBBP Q92793 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ACLY P53396 1/20 0.35
PSMD14 O00487 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
PTPN7 P35236 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14331256 0.92 CYP2C19 (0.41) CYP2C19KMOSETD2PRKDCCYP3A4
SCHEMBL2534812 0.90 SETD2 (0.40) CYP2C19KMOSETD2PRKDCCYP3A4
SCHEMBL2532883 0.89 CYP2C19 (0.43) CYP2C19KMOPRKDCCYP3A4KIF11
SCHEMBL2531707 0.86 SETD2 (0.39) CYP2C19KMOSETD2PRKDCCYP3A4
SCHEMBL2529373 0.85 CYP2C19 (0.43) CYP2C19KMOSETD2PRKDCCYP3A4
SCHEMBL2527845 0.84 CYP2C19 (0.43) CYP2C19KMOSETD2PRKDCCYP3A4
SCHEMBL2530945 0.84 CYP2C19 (0.43) CYP2C19KMOSETD2CYP3A4KIF11
SCHEMBL2536455 0.83 CYP2C19 (0.44) CYP2C19KMOPRKDCCYP3A4KIF11
SCHEMBL2534968 0.82 CYP2C19 (0.43) CYP2C19KMOPRKDCCYP3A4KIF11
SCHEMBL14331219 0.81 CYP2C19 (0.41) CYP2C19KMOPRKDCCYP3A4KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558449-B1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-05 EP disclosed
US-8586747-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2013-11-19 US disclosed
EP-2558449-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2013-02-20 EP disclosed
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES Hoffmann-La Roche Inc (US) 2013-01-24 US disclosed
US-8344137-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMAN-LA ROCHE INC. (US) 2013-01-01 US disclosed
WO-2011128251-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO disclosed
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HUA MEDICINE (KY) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 CYP2C19 273/4885KMO 2473/4885SETD2 436/4885
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 CYP2C19 273/4885KMO 2473/4885SETD2 436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.